Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Targets for therapy in ETP-ALL
Prof Jan Cools - University of Leuven, Belgium
Targets for therapy in ETP-ALL ( Prof Jan Cools - University of Leuven, Belgium )
27 Jan 2017
The role of autologous transplant in ALL
Prof Sebastian Giebel - Silesian Medical University, Katowice, Poland
The role of autologous transplant in ALL ( Prof Sebastian Giebel - Silesian Medical University, Katowice, Poland )
27 Jan 2017
Pathologic diagnosis of monoclonal gammopathy
Dr Rocío Orduz - Organización Sanitas Internacional, Bogotá, Colombia
Pathologic diagnosis of monoclonal gammopathy ( Dr Rocío Orduz - Organización Sanitas Internacional, Bogotá, Colombia )
6 Jan 2017
ASH 2016: Multiple myeloma highlights
Prof Marivi Mateos, Prof Philippe Moreau, Prof Saad Usmani, Prof Heinz Ludwig
ASH 2016: Multiple myeloma highlights ( Prof Marivi Mateos, Prof Philippe Moreau, Prof Saad Usmani, Prof Heinz Ludwig )
6 Dec 2016
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin...
Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma ( Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )
6 Dec 2016
Pacritinib versus best available therapy for low platelet Myelofibrosis
Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA
Pacritinib versus best available therapy for low platelet Myelofibrosis ( Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA )
6 Dec 2016
Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL
Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA
Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL ( Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA )
6 Dec 2016
DVd vs Vd for relapsed or refractory myeloma: CASTOR trial update
Prof Marivi Mateos - University Hospital of Salamanca, Salamanca, Spain
DVd vs Vd for relapsed or refractory myeloma: CASTOR trial update ( Prof Marivi Mateos - University Hospital of Salamanca, Salamanca, Spain )
6 Dec 2016
ASH 2016 highlights: breaking new ground in haematology
Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy
ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )
6 Dec 2016
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML...
Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients ( Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA )
6 Dec 2016
Azacitidine plus nivolumab against acute myeloid leukaemia
Prof Naval Daver - MD Anderson Cancer Center, Houston, USA
Azacitidine plus nivolumab against acute myeloid leukaemia ( Prof Naval Daver - MD Anderson Cancer Center, Houston, USA )
6 Dec 2016
IKZF1 mutations associated with paediatric ALL
Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA
IKZF1 mutations associated with paediatric ALL ( Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA )
5 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation